Ochre Bio develops genomic medicines to rejuvenate fatty donor livers before transplant, so that everyone who needs a new liver gets one.
Location: United Kingdom, England, Oxford
Employees: 11-50
Total raised: $39.6M
Founded date: 2019
Investors 8
| Date | Name | Website |
| - | Pathway Bi... | pathwaybio... |
| 17.04.2022 | Khosla Ven... | khoslavent... |
| - | Expa | expa.com |
| 05.02.2022 | Y Combinat... | ycombinato... |
| - | Norrsken V... | norrsken.v... |
| 14.01.2022 | Thomas McI... | tgm.com |
| 24.02.2022 | Lifeforce ... | lifeforcec... |
| - | Bioverge | ventures.b... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 21.10.2022 | Series A | $30M | - |
| 21.06.2021 | Seed | $9.6M | Khosla Ven... |
Mentions in press and media 10
| Date | Title | Description | Source |
| 21.10.2022 | Ochre Bio closes €30M Series A funding round | EIT Health-supported Ochre Bio has closed a Series A funding round of €30M. As a participant of our ... | eithealth.... |
| 10.10.2022 | RNA therapies startup Ochre Bio lands $30M to take on chroni... | Ochre Bio co-founders Quin Wills, chief scientific officer (left), and Jack O’Meara, CEO (right). Ph... | medcitynew... |
| 20.07.2021 | Calling all UK tech firms: UK government’s new €434.6M schem... | Today, the new £375M (approx €434.68M) Future Fund: Breakthrough — announced by the Chancellor of th... | siliconcan... |
| 21.06.2021 | Ochre Bio Raises $9.6M in Seed Financing | Ochre Bio, an Oxford, England, UK-based biotech company developing RNA medicines for chronic liver d... | finsmes.co... |
| 16.06.2021 | In private equity, compensation lags for women in senior pos... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 16.06.2021 | Ochre Bio : Closes $9.6M Seed Financing Led by Khosla Ventur... | Ochre Bio, a biotech company developing RNA medicines for chronic liver diseases, today announced th... | marketscre... |
| 16.06.2021 | In private equity, compensation lags for women in senior pos... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 17.03.2020 | All the companies from Y Combinator’s W20 Demo Day, Part IV:... | Y Combinator’s Demo Day was a bit different this time around. As concerns grew over the spread of C... | techcrunch... |
| - | Ochre Bio | “Ochre Bio is developing therapies for the biggest liver health challenges.” | fastfounde... |
| - | StartUPDATES: New developments from healthcare startups | HealthMine is thrilled to announce a new partnership with Zing Health, an innovative, tech-enabled M... | medcitynew... |